Two articles published recently conclude that influenza is associated with a significant mortality and morbidity burden in Bangladesh (Ahmed et al., 2018) and Rwanda (Nyamusore et al., 2018) . This is a matter of high relevance for public health, as it brings into consideration the introduction of annual influenza immunization campaigns in countries with severe competing priorities in public health. Bangladesh and Rwanda are both tropical countries, with mild winters. This is often good news as far as influenza burden is concerned, as there are indications that not only is influenza seasonality different in tropical regions (Alonso et al., 2015) , but also associated with a considerably lower burden. Recently, the 2009 pandemic provided us with an additional opportunity to put this hypothesis on trial as, different from other years, the fraction of respiratory mortality attributable to the influenza relative to co-circulating pathogens could be identified much more clearly (given anomalies in the timing and amplitude in the temporal signal of deaths and hospitalizations caused by the pandemic). That hypothesis had support first in Brazil, a country with a relatively homogeneous public health system and immunization policies, yet spanning a wide range of latitudes and climates: while in nonequatorial regions of Brazil H1N1pdm was clearly associated with excess mortality rates (mainly in the southernmost states) (Freitas, Francisco & Donalisio, 2013; Freitas & Donalisio, 2018) , the pandemic produced no noticeable anomalies in equatorial regions of Brazil (the poorest) . Additionally, and contrary to what was claimed, our analyses showed that H1N1pdm also did not affect mortality rates in Madagascar at that time (Alonso & Schuck-Paim, 2013 ). WHO's updates on the pandemic and subsequent studies also failed to detect a higher flu burden during the pandemic in other tropical regions (World Health Organization, 2010; Nzussouo et al., 2012 ) .
So we analyzed with great interest the recent claim of a relatively high influenzaassociated mortality burden in Bangladesh (of 6 and 11 deaths per 100,000 population, respectively, in 2010-11 and 2011-12) and hospitalization burden in Rwanda. While doing so, we detected a poor match between the temporal signature of influenza virus detection and ARI cases Figure 2 of the Bangladeshi paper (Ahmed et al., 2018) shows that influenza circulation is out of phase with ARI-associated deaths; the lack of a match is particularly pronounced in the population older than 60 years, for which peaks in mortality (Dec-Feb) happen when influenza activity was at its lowest. In the case of the Rwandan study, no data on the seasonal patterns of influenza activity and hospitalization rates is provided (the authors "used annual influenza virus detection rate because the number of SARI cases enrolled did not display seasonal variations (data not shown)" (Nyamusore et al., 2018) A similar situation had been previously observed in an equatorial city in Brazil: when the timing of events was dissected closely, influenza circulation was found to be out of phase -by five weeks -with pneumonia & influenza attributed deaths . The absence of respiratory syncytial virus (RSV) tests in these two studies from Bangladesh and Rwanda may have also contributed to distortions, as RSV has been shown to be associated with a substantial disease burden in all age groups (Fleming & Cross, 1993; Fleming et al., 2015) . This may have been particularly accentuated in Rwanda where there was an estimate of disproportionately high hospitalization among younger children who are usually the most affected by this virus.
We must also consider the more general difficulties associated with the attribution of disease burden to a specific pathogen when many of the deaths were in fact of patients with severe chronic conditions. Should the death of a terminal cancer patient who was infected with influenza be attributed to influenza or cancer? For public health policy considerations, would the introduction of influenza vaccines spare a high number of lives in this context, particularly in light of the observation that it would not have prevented most (e.g. 87% in Bangladesh) ARI and SARI cases? These observations make us reluctant about the claim of a "heavier burden of influenza-associated severe illness on the continent" (Nyamusore et al., 2018) or the "substantial burden of seasonal influenza in the population of Bangladesh" (particularly in light of the 25-fold difference in the estimated seasonal mortality burden between this study and that of previous approach -0.23 deaths/100,000 population -i.e. that does consider the problem of competing attributions of disease burden(Institute for Health Metrics and Evaluation (IHME), 2017)).
We congratulate the authors of those studies for bringing more data into this relevant discussion, but suggest that the issues discussed here are considered in a putative recommendation of seasonal influenza vaccines in tropical settings.
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